Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Higher cholesterol levels increase aggressive prostate cancer risk.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Current therapies cannot fully regenerate adult skin without scars; more research is needed for scar-free healing.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.